Tamar Sadan
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 9
- Biomaterials 12
- Nanoparticle-Based Drug Delivery 12
- Co-authors
- Rachela Popovtzer (25 shared papers)Oshra Betzer (13 shared papers)Menachem Motiei (22 shared papers)Daniel Offen (2 shared papers)Nisim Perets (2 shared papers)Ariel Angel (2 shared papers)Gal Yadid (1 shared paper)Uri Ashery (1 shared paper)
In The Last Decade
Tamar Sadan
25 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 112
- Cancer Research 346
- Biomaterials 234
- Molecular Biology 761
- Biomedical Engineering 453
- Neurology 63
Countries citing papers authored by Tamar Sadan
This map shows the geographic impact of Tamar Sadan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamar Sadan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamar Sadan more than expected).
Fields of papers citing papers by Tamar Sadan
This network shows the impact of papers produced by Tamar Sadan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamar Sadan. The network helps show where Tamar Sadan may publish in the future.
Co-authors
The 25 scholars most cited alongside Tamar Sadan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 341 | |
| 2 | 2019 | 328 | |
| 3 | 2017 | 106 | |
| 4 | 2020 | 104 | |
| 5 | 2019 | 78 | |
| 6 | 2005 | 61 | |
| 7 | 2021 | 49 | |
| 8 | 2020 | 45 | |
| 9 | 2019 | 44 | |
| 10 | 2017 | 24 | |
| 11 | 2020 | 23 | |
| 12 | 2019 | 22 | |
| 13 | 2018 | 20 | |
| 14 | 2022 | 16 | |
| 15 | 2020 | 10 | |
| 16 | 2020 | 8 | |
| 17 | 2024 | 7 | |
| 18 | 2021 | 4 | |
| 19 | 2018 | 4 | |
| 20 | 2022 | 3 |
About Tamar Sadan
Tamar Sadan is a scholar working on Biomedical Engineering, Biomaterials, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (12 papers), Nanoplatforms for cancer theranostics (9 papers), RNA Interference and Gene Delivery (5 papers), Gold and Silver Nanoparticles Synthesis and Applications (4 papers), Extracellular vesicles in disease (4 papers), Immunotherapy and Immune Responses (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Cancer Research (346 citations), Biomaterials (234 citations), Molecular Biology (761 citations), Biomedical Engineering (453 citations) and Neurology (63 citations). Tamar Sadan has collaborated with scholars based in Israel, China and Russia. Frequent co-authors include Rachela Popovtzer, Oshra Betzer, Menachem Motiei, Daniel Offen, Nisim Perets, Ariel Angel, Gal Yadid, Uri Ashery, Zhuang Liu and Katerina Shamalov. Their work appears in journals such as ACS Nano, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology, Nanomedicine, Nanomedicine Nanotechnology Biology and Medicine and Biomacromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.